<?xml version="1.0" encoding="UTF-8"?>
<p>Hypertensive control animals displayed significant (
 <italic>p</italic> &lt; 0.01) increases in serum total protein (79.10%), and ALAT (32.84%) and ASAT (53.99%) activities compared with the control group (
 <xref rid="tab5" ref-type="table">Table 5</xref>). Treatment with captopril or extract doses 100 and 200 mg/kg significantly reduced (
 <italic>p</italic> &lt; 0.001) ALAT and ASAT activities (27.87%, 30.69%, and 31.07%, and 57.42%, 47.23 %, and 49.69%, respectively) compared to hypertensive control group (
 <xref rid="tab5" ref-type="table">Table 5</xref>). The increase in blood total protein observed in the hypertensive control group was mitigated significantly (
 <italic>p</italic> &lt; 0.01) in the groups treated with extract dose 100 mg/kg (23.33% compared to the hypertensive control group), dose 200 mg/kg (26.67%), and captopril (25.83%) (
 <xref rid="tab5" ref-type="table">Table 5</xref>).
</p>
